You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

17p Deletion CLL

Showing 1 - 25 of 1,276
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

Terminated
Has Results
  • CLL
  • SLL
  • Boston, Massachusetts
  • +1 more
Jan 30, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

Completed
  • Leukemia, Lymphocytic, Chronic
  • Dresden, Germany
  • +10 more
Jan 13, 2023

Leukemia, Leukemia, Lymphocytyc, CLL (Chronic Lymphocytic Leukemia) Trial run by the NHLBI (PCI 32765)

Active, not recruiting
Has Results
  • Leukemia
  • +3 more
  • PCI 32765
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 2, 2021

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Tempe, Arizona
  • +14 more
Jan 12, 2022

Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Bad Saarow, Germany
  • +29 more
May 4, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Louisville, Kentucky
  • +66 more
Nov 9, 2022

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Multiple Myeloma, Deletion 17P Syndrome Trial in Italy (Daratumumab, Pomalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Deletion 17P Syndrome
    • Ancona, Italy
    • +14 more
    Mar 24, 2022

    Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

    Completed
    • Chronic Lymphocytic Leukemia
      • Calgary, Alberta, Canada
      • +12 more
      Jul 7, 2022

      Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

      Completed
      Has Results
      • Chronic Lymphocytic Leukemia
      • +2 more
      • ABT-199 (Main Cohort)
      • ABT-199 (Safety Expansion Cohort)
      • Tucson, Arizona
      • +47 more
      Nov 19, 2021

      Chronic Lymphocytic Leukemia Trial in San Diego (ISF35)

      Completed
      • Chronic Lymphocytic Leukemia
      • ISF35
      • San Diego, California
        University of California, San Diego Moores Cancer Center
      Sep 15, 2021

      Chronic Lymphocytic Leukemia Trial (Zebutinib&BR or Zebutinib&FCR)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Zebutinib&BR or Zebutinib&FCR
      • (no location specified)
      Jul 27, 2021

      Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Aurora, Colorado
      • +55 more
      Jan 30, 2023

      Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax)

      Completed
      • Chronic Lymphocytic Leukemia (CLL)
      • La Plata, Buenos Aires, Argentina
      • +32 more
      Feb 10, 2022

      Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

      Completed
      • Loss of Chromosome 17p
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 4, 2022

      Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
      • (no location specified)
      Dec 27, 2022

      Chronic Lymphocytic Leukemia Trial in Austria, France, Germany (Alemtuzumab)

      Completed
      • Chronic Lymphocytic Leukemia
      • Wien, Austria
      • +37 more
      Oct 21, 2019

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Cyclophosphamide, Fludarabine Phosphate, Ibrutinib)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Leukemia
      • (no location specified)
      Nov 30, 2022

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Lymphoma
      • Boston, Massachusetts
      • +2 more
      Mar 16, 2022

      Chronic Lymphocytic Leukemia Trial in Cologne (lenalidomide, Placebo)

      Completed
      • Chronic Lymphocytic Leukemia
      • Cologne, Germany
      • +1 more
      Dec 16, 2021

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the NHLBI (Ibrutinib, Fludarabine)

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Mar 1, 2022

      Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

      Active, not recruiting
      Has Results
      • Small Lymphocytic Lymphoma
      • CLL (Chronic Lymphocytic Leukemia)
      • Fludarabine Phosphate
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 13, 2022